Heliyon (Mar 2019)
Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]
- Xiaosheng Wu,
- Yanli Li,
- Xin Liu,
- Chunhua Chen,
- Susan M. Harrington,
- Siyu Cao,
- Tiancheng Xie,
- Tu Pham,
- Aaron S. Mansfield,
- Yiyi Yan,
- Eugene D. Kwon,
- Liewei Wang,
- Kun Ling,
- Haidong Dong
Affiliations
- Xiaosheng Wu
- Department of Medicine Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Yanli Li
- Department of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Xin Liu
- Department of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Chunhua Chen
- Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Susan M. Harrington
- Department of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Siyu Cao
- Department of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Tiancheng Xie
- Department of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Tu Pham
- Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Aaron S. Mansfield
- Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Yiyi Yan
- Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Eugene D. Kwon
- Department of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Liewei Wang
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA
- Kun Ling
- Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA
- Haidong Dong
- Department of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA; Corresponding author.
- Journal volume & issue
-
Vol. 5,
no. 3
p. e01309
